Item 7.01 Regulation FD Disclosure.
As previously announced,
In connection with the proposed Transaction, the Company and GVS will also enter into a long-term supply and development agreement that will, among other things, grant GVS exclusive rights to manufacture and supply the blood filters currently produced at the Fajardo facility for the Company. The Company will also provide certain transition services to GVS under a transition services agreement to be entered into between the parties, generally for a period of up to three months following the closing of the Transaction.
The Transaction is expected to close in the second quarter of calendar 2020,
subject to the satisfaction of customary closing conditions. A copy of the
Company's
Cautionary Note Regarding Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements about the
Transaction, including, but not limited to, statements related to the
anticipated closing of the Transaction, the estimated cash proceeds to be
received and other statements that are not historical facts. Such
forward-looking statements are not meant to predict or guarantee actual results,
performance, events or circumstances and may not be realized because they are
based upon the Company's current projections, plans, objectives, beliefs,
expectations, estimates and assumptions and are subject to a number of risks and
uncertainties and other influences. Actual results and the timing of certain
events and circumstances may differ materially from those described by the
forward-looking statements as a result of these risks and uncertainties, which
include, without limitation, the risks that the Transaction may not close in a
timely manner or at all, that the Company may not realize the anticipated
benefits of the Transaction or that the Transaction may have an unanticipated
impact. Investors should consult the Company's filings with the
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press release datedJune 3, 2020 .
--------------------------------------------------------------------------------
© Edgar Online, source